- Conditions
- Staphylococcal Sepsis
- Interventions
- Placebo, Pagibaximab 50 mg/mL
- Drug
- Lead sponsor
- Biosynexus Incorporated
- Industry
- Eligibility
- Up to 48 Hours
- Enrollment
- 1,579 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2011
- U.S. locations
- 1
- States / cities
- Gaithersburg, Maryland
Source: ClinicalTrials.gov public record
Updated Oct 23, 2011 · Synced May 21, 2026, 9:51 PM EDT